Live Breaking News & Updates on Dermatitis

Stay informed with the latest breaking news from Dermatitis on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Dermatitis and stay connected to the pulse of your community

Extension Data Reported for Chronic Hand Eczema Treatment

Over 1 year after phase 3 studies suggested that delgocitinib cream was safe and effective for chronic hand eczema, extension data indicate that control persists without new safety issues.

Japan , Illinois , United-states , San-diego , California , Northwestern-university , Chicago , Canada , American , Raj-chovatiya , Melissa-gooderham , European-academy-of-dermatology

Expert Recommends Phased Approach For Delusional Infestation

Phase 4 involves initiating therapy, which includes demonstrating empathy by reflecting on the detrimental effects of the patient's reported sensations on their quality of life.

California , United-states , Mountain-view , San-francisco , Palo-alto , American , Jennye-murase , Palo-alto-foundation-medical-group , American-academy-of-dermatology , University-of-california , International-journal-of-dermatology

Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa

Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.

United-states , California , University-of-southern-california , Boston , Massachusetts , American , Martinaj-porter , P-jenniferl-hsiao , Los-angeles , Beth-israel-deaconess-medical-center , Harvard-medical-school , American-academy-of-dermatology

Nemolizumab Being Reviewed for AD, Prurigo Nodularis

For prurigo nodularis, the FDA has granted nemolizumab, a monoclonal antibody designed to inhibit interleukin-31 signaling, priority review.

Drug-administration , European-medicines-agency , Biologics-license-application , Marketing-authorization-applications , Biologic-therapy , Iologics , Prurigo-nodularis , Dermatitis , Atopic-dermatitis , Topic-eczema , Grant

What Skin Manifestations Are Associated With Pediatric IBD?

Skin conditions both specific and nonspecific to IBD are prevalent in children and adolescents with IBD, with infectious conditions being the most common.

Minnesota , United-states , Megham-tollefson , Department-of-dermatology-at-mayo-clinic , Mayo-clinic , Inflammatory-bowel-disease-ibd , Children , Hild , Hildhood , Ediatrics , Ids

Tapinarof Under FDA Review for Treating Atopic Dermatitis

Approved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older.

Drug-administration , Dermavant-sciences , New-drug-application , Validated-investigator-global-assessment , Atopic-dermatitis , Dermatitis , Topic-eczema , Children , Hild , Hildhood , Ediatrics

Exploring health benefits of dry salt therapy at Latham's Salt Den

These days, it seems like everyone is looking for new ways to relax. One of those ways is with salt.It's dark, cozy and mostly quiet. The only sound is the crun

Robert-duff , Therapies-in-health , Capital-region , Salt-den , Health-medical-pharma , Halotherapy , Speleotherapy , Hydrotherapy , Asthma , Dermatitis , Naturopathy , Salt

Lab Testing in Patients on Immunomodulators Falls Short

Review found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment.

Massachusetts , United-states , Eastern-virginia-medical-school , Virginia , Cambridge , Cambridgeshire , United-kingdom , Washington , Harvard-university , Boston , Norfolk , Mariac-schneeweiss